| Property | Value |
|---|
|
?:abstract
|
-
Background: In 2015, an outbreak of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infection occurred in South Korea involving 186 patients, 39 of whom were healthcare workers (HCWs) exposed to the infection An effective post-exposure prophylaxis (PEP) strategy may limit the spread of infection;however, there is no consensus regarding PEP for MERS-CoV infection In this study, we assessed (1) the efficacy of oral ribavirin and lopinavir/ritonavir as PEP for HCWs exposed to patients with severe MERS-CoV pre-isolation pneumonia, and (2) safety of the PEP regimen Methods: We retrospectively enrolled 43 HCWs with high-risk exposure to MERS-CoV from 5 hospitals affected during this outbreak in South Korea The rate of MERS-CoV infection was compared between 22 workers at 1 hospital who received PEP consisting of oral ribavirin and lopinavir/ritonavir after exposure to patients with severe MERS-CoV pre-isolation pneumonia and 21 workers at other hospitals who did not receive PEP Results: Six workers (14%) developed MERS-CoV infection;all of these subjects belonged to the non-PEP group The attack rate was lower in the PEP group compared with the non-PEP group (0% vs 28 6%;Odds ratio = 0 405, 95% confidence interval = 0 274–0 599;P = 0 009) The most commonly reported side effects of PEP therapy were nausea and diarrhea, but there were no severe adverse effects associated with PEP therapy Conclusion: PEP with a combination of oral ribavirin and lopinavir/ritonavir appears to be effective and generally safe for preventing MERS-CoV infection after high-risk exposure in healthcare workers Disclosures: All authors: No reported disclosures FAU - Park, So Yeon
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Open_Forum_Infectious_Diseases
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
2491. Post-Exposure Prophylaxis With Ribavirin Plus Lopinavir/Ritonavir for Middle East Respiratory Syndrome in Healthcare Workers
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}